Joseph Barbera, MD
Orthopaedic Surgery · Hialeah, FLNPI 1174029771
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (38.4%), education and food and beverage — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 77.4% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2024 at $6,961 and has fallen 96.7% since, to $231 in 2025.
Across 28 payments — averaging $465.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$10K
- Medical Device Business Services, Inc.$2K
- Zimmer Biomet$599
- Stryker$379
- Kerecis Limited$217
- Medtronic$129
- plus $70 from 3 others
What the payments were for
- Grants$5,00038%
- Travel & lodging$1,29010%
- Food & beverage$1,74313%
- Education$5,00038%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 3 | $10,081 |
| Medical Device Business Services, Inc. | 9 | $1,557 |
| Zimmer Biomet | 4 | $599 |
| Stryker | 6 | $379 |
| Kerecis Limited | 2 | $217 |
| Medtronic | 1 | $129 |
| ERMI LLC | 1 | $30 |
| Linkbio Corp | 1 | $21 |
| Exact Sciences | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACTIS$1,432
- Kerecis Omega3 SurgiClose$438
- ROSA$272
- T2 ALPHA$161
- SALVATION$158
- Kerecis Omega3 GraftGuide$146
- Kerecis Omega3 Marigen$146
- CD HORIZON SPINAL SYSTEM$129
How this compares
$13,033 in reported general payments places this provider in the 65th percentile of 1,263 orthopaedic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 17 | $4,576 |
| Celecoxib | 164 | $4,051 |
| Ondansetron OdtOndansetron | 163 | $1,364 |
| Oxycodone Hcl | 146 | $674 |
| Tramadol Hcl | 165 | $504 |
| Cefadroxil | 34 | $162 |
| Tamsulosin Hcl | 15 | $38 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Hialeah
- Andrew CooperClearwater$102M
- Richard HynesMelbourne$34.8M
- Mark FrankleTemple Terrace$31M
- Roy SandersTemple Terrace$19.6M
- George HaidukewychOrlando$10M
- Robert SantrockFernandina Beach$7.3M
- Martin RocheFt. Lauderdale$7.1M
- Steven LyonsTampa$6.7M
- Thomas BernasekTemple Terrace$6.4M
- Bryan SpringerJacksonville$6.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.